Literature DB >> 15644628

Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke.

Kazuhiko Nakagawa1, Takekane Yamaguchi, Mitsuru Seida, Shimpei Yamada, Shogo Imae, Yoji Tanaka, Kiyotaka Yamamoto, Kikuo Ohno.   

Abstract

BACKGROUND: Acute blood pressure (BP) elevation and cardiac abnormalities are known to follow ischemic stroke. Brain natriuretic peptide (BNP), which is produced in response to such cardiovascular alterations, is expected to play a hemodynamic role. We measured plasma BNP concentrations in patients with cerebral infarction (CI) to determine the implications of BNP in acute ischemic stroke.
METHODS: Eighty-eight patients with CI, 59 with essential hypertension, 44 with spontaneous intracerebral hemorrhage, 22 with asymptomatic atrial fibrillation (Af), and 20 age- and sex-matched healthy volunteers were recruited in the study. CI patients were divided into 2 subgroups either having Af (27 patients) or not (61 patients). BNP levels were repeatedly measured in 58 patients with CI. BNP levels were compared between ischemic subgroups categorized by size of infarction. Correlation was investigated between BNP levels and hemodynamic parameters.
RESULTS: BNP levels in CI patients were significantly higher, but they decreased in the subacute period. BNP levels in CI patients without Af were correlated with mean arterial blood pressure (MAP) on admission or the degree of reduction in MAP at day 1, while in CI patients with Af BNP levels showed negative correlation with MAP on admission. Follow-up serum sodium levels in CI patients with Af were negatively correlated with BNP levels on admission.
CONCLUSIONS: This study suggests the hemodynamic implications of BNP in acute ischemic patients. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644628     DOI: 10.1159/000083249

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  19 in total

Review 1.  Blood biomarkers of ischemic stroke.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease.

Authors:  John Gunstad; Athena Poppas; Steven Smeal; Robert H Paul; David F Tate; Angela L Jefferson; Daniel E Forman; Ronald A Cohen
Journal:  Am J Cardiol       Date:  2006-06-28       Impact factor: 2.778

3.  Biomarker panels in ischemic stroke.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Stroke       Date:  2015-02-05       Impact factor: 7.914

4.  A prospective study of brain natriuretic peptide levels in three subgroups: Stroke with hypertension, stroke without hypertension, and hypertension alone.

Authors:  Zeynep Cakir; Ayhan Saritas; Mucahit Emet; Sahin Aslan; Ayhan Akoz; Fuat Gundogdu
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 5.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

6.  Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Authors:  W T Longstreth; Richard A Kronmal; John L P Thompson; Robert H Christenson; Steven R Levine; Rebecca Gross; Robin L Brey; Richard Buchsbaum; Mitchell S V Elkind; David L Tirschwell; Stephen L Seliger; J P Mohr; Christopher R deFilippi
Journal:  Stroke       Date:  2013-01-22       Impact factor: 7.914

7.  S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.

Authors:  Michael L James; Robert Blessing; Barbara G Phillips-Bute; Ellen Bennett; Daniel T Laskowitz
Journal:  Biomarkers       Date:  2009-09       Impact factor: 2.658

8.  B-type natriuretic peptide as a marker for heart failure in patients with acute stroke.

Authors:  Matthew A Koenig; H Adrian Puttgen; Vivek Prabhakaran; Daniel Reich; Robert D Stevens
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 17.440

9.  Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients.

Authors:  Henrik Reinhard; Ellen Garde; Arnold Skimminge; Per Åkeson; Thomas Zoëga Ramsøy; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2012-10-03       Impact factor: 9.951

10.  Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume.

Authors:  Seo Hyun Kim; Ji-Yong Lee; Sang Hyun Park; Hyun-Chan Jang; Eun Ju Lim; Sei-Jin Chang; Sung-Soo Lee
Journal:  Int J Med Sci       Date:  2012-12-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.